Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients

Phase 2 Terminated 9 enrolled University of Kansas Medical Center

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to learn if using a Entocort (budesonide) to treat diarrhea will be effective and safe for kidney transplant patients, allowing them to continue with MPA medication.

Timeline

Start: 2017-01-27
Primary completion: 2019-04-26
Completion: 2019-04-26

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Budesonide	Small molecule	6 mg	Oral

Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients

Summary

Timeline

Drugs

Indications